KROS
Keros Therapeutics Inc.
$15.21
-$0.04(-0.26%)
35
Overall
--
Value
40
Tech
31
Quality
Market Cap
$605.58M
Volume
586.02K
52W Range
$9.12 - $72.37
Target Price
$23.33
EPS Estimates Overview
| Current Quarter | $-1.11 | Next Quarter | $-1.11 |
| Current Year | $0.33 | Next Year | $-4.78 |
| QoQ Growth | +0.0% | YoY Growth | -1548.5% |
| 3Y EPS CAGR | -18.7% | Target Price | $23.33 |
| Consensus | Buy | Upside | +53.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $15.21 | -0.3% | 586.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |